date,title,source
Oct-31-18,Forty Seven Inc. Announces Publication in The New England Journal of Medicine of 5F9 Phase 1b Clinical Data in Non-Hodgkins Lymphoma (NHL),GlobeNewswire
Nov-01-18,Forty Seven Inc. to Present New Preclinical Data on 5F9 at the 60th American Society of Hematology (ASH) Annual Meeting,GlobeNewswire
Nov-07-18,Forty Seven Inc. to Present at the Credit Suisse 27th Annual Healthcare Conference,GlobeNewswire
Nov-13-18,Forty Seven Inc. Reports Third Quarter 2018 Financial Results and Recent Business Highlights,GlobeNewswire
Dec-21-18,"Should You Take Comfort From Insider Transactions At Forty Seven, Inc. (NASDAQ:FTSV)?",Simply Wall St.
Jan-02-19,Here are the winners and losers from Bay Area's IPO class of 2018,American City Business Journals
